Company: APTV
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001521332-25-000040
Chunk: 49

Company: Aptiv PLC
Filing Date: 2025-07-31
Form: 10-Q
Item: Item 1
Chunk 49
---
 earnings only when such securities are sold, or an allowance for expected credit losses or impairment is recognized.As further described in Note 21. Investments in Affiliates, the Company owns investments in Maxieye and StradVision, which are classified as available-for-sale debt securities due to the Company’s redemption rights, and are included within other long-term assets in the consolidated balance sheets. The fair value measurements of these investments are based on significant inputs that are not observable in the market, and are therefore classified as a Level 3 measurement. 

34

The below table summarizes the cost, cumulative unrealized gains, cumulative unrealized losses and estimated fair value of Aptiv’s debt securities as of June 30, 2025 and December 31, 2024:Cost basisGross unrealized gainsGross unrealized lossesEstimated fair value (in millions)As of June 30, 2025Available-for-sale debt securities$205 $18 $(12)$211 Total debt securities$205 $18 $(12)$211 As of December 31, 2024Available-for-sale debt securities$165 $8 $(12)$161 Total debt securities$165 $8 $(12)$161 The change in fair value of available-for-sale debt securities classified as a Level 3 measurement for the six months ended June 30, 2025 and 2024 are as follows:Six Months Ended June 30,20252024 (in millions)Fair value at beginning of period$161 $— Additions40 84 Measurement adjustments10 — Fair value at end of period$211 $84 There were no impairment charges related to these investments during the three and six months ended June 30, 2025 and 2024.As of June 30, 2025 and December 31, 2024, Aptiv had the following assets measured at fair value on a recurring basis:TotalQuoted Prices in Active MarketsLevel 1Significant Other Observable InputsLevel 2Significant Unobservable InputsLevel 3 (in millions)As of June 30, 2025:Commodity derivatives$20 $— $20 $— Foreign currency derivatives34 — 34 — Publicly traded equity securities11 11 — — Available-for-sale debt securities211 — — 211 Total$276 $11 $54 $211 As of December